Quantitation of intracellular triphosphate of emtricitabine in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 9, 1999, Pages 2245-2250

  Darque, Albert ^a   Valette, Gilles ^a   Rousseau, Frank ^b   Wang, Laurene H ^b   Sommadossi, Jean Pierre ^a,c   Zhou, Xiao Jian ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Triangle Pharmaceuticals   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DRUG DERIVATIVE; EMTRICITABINE; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG OXIDATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VALIDATION PROCESS;

EID: 0032874225     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.9.2245     Document Type: Article

References (26)

1. Delehanty, J., C. Wakeford, L. Hulett, J. Quinn, B. McCreedy, M. Almond, D. Miralles, and F. Rousseau. 1999. A phase I/II randomized controlled study of FTC versus 3TC in HIV-infected patients, abstr. 16, p. 70. In Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology and Human Health, Alexandria, Va.
2. Doong, S. L., C. H. Tsai, R. F. Schinazi, D. C. Liotta, and Y. C. Cheng. 1991. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc. Natl. Acad. Sci. USA 88:8495-8499.
3. Drusano, G. L., G. L. Yuen, J. S. Lambert, M. Seidlin, R. Dolin, and F. T. Valentine. 1992. Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial. Ann. Intern. Med. 116:562-566.
4. Fletcher, C. V., S. P. Kawle, L. M. Page, R. P. Remmel, E. P. Acosta, K. Henry, A. Erice, and H. H. Balfour. 1997. Intracellular triphosphate concentrations of antiretroviral nucleosides as a determinant of clinical response in HIV-infected patients, abstr. 13, p. 67. In Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology and Human Health, Alexandria, Va.
5. Furman, P. A., M. Davis, D. C. Liotta, M. Paff, L. W. Frick, D. J. Nelson, R. E. Dornsife, J. A. Wurster, L. J. Wilson, J. A. Fyfe, J. V. Tuttle, W. H. Miller, L. Condreay, D. R. Averett, R. F. Schinazi, and G. R. Painter. 1992. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 36:2686-2692.
6. Ganem, D., and H. E. Varmus. 1987. The molecular biology of hepatitis B virus. Annu. Rev. Biochem. 56:651-693.
7. Gao, W. Y., T. Shirasaka, D. G. Johns, S. Broder, and H. Mitsuya. 1993. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J. Clin. Investig. 91:2326-2333.
8. Kuster, H., M. Vogt, B. Joos, V. Nadai, and R. Luthy. 1991. A method for the quantification of intracellular zidovudine nucleotides. J. Infect. Dis. 164:773-776.
9. Lee, W. M. 1997. Medical progress: hepatitis B virus infection. N. Engl. J. Med. 334:1733-1745.
10. Paff, M. A., D. R. Averett, K. L. Prus, W. H. Miller, and D. J. Nelson. 1994. Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2.2.15 (subclone P5A) cells. Antimicrob. Agents Chemother. 38:1230-1238.
11. Robbins, B. L., B. H. Waibel, and A. Fridland. 1996. Quantitation of intracellular zidovudine phosphates by use of combined cartridge-radioimmunoassay methodology. Antimicrob. Agents Chemother. 40:2651-2654.
12. Robbins, B. L., J. Rodman, C. McDonald, R. V. Srinivas, P. M. Flynn, and A. Fridland. 1994. Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 38:115-121.
13. Robbins, B. L., T. T. Tran, F. H. Pinkerton, Jr., F. Akeb, R. Gnedj, J. Grassi, D. Lancaster, and A. Fridland. 1998. Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 42:2656-2660.
14. Schinazi, R. F., A. McMillan, D. Cannon, R. Mathis, R. M. Lloyd, A. Peck, J. P. Sommadossi, M. St. Clair, J. Wilson, P. A. Funnan, G. R. Painter, W. B. Choi, and D. C. Liotta. 1992. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 36:2423-2431.
15. Slusher, J. T., S. K. Kuwahara, F. M. Hamzeh, L. D. Lewis, D. M. Kornhauser, and P. S. Lietman. 1992. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure. Antimicrob. Agents Chemother. 36:2473-2477.
16. Solas, C., Y.-F. Li, M.-Y. Xie, J.-P. Sommadossi, and X.-J. Zhou. 1998. Intracellular nucleotides of (-)-2′,3′-deoxy-3′-thiacytidine in peripheral blood mononuclear cells of a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 42:2989-2995.
17. Sommadossi, J. P. 1994. Treatment of hepatitis B by nucleoside analogs: still a reality. Curr. Opin. Infect. Dis. 7:678-682.
18. Sommadossi, J. P., M. A. Valentin, X. J. Zhou, M. Y. Xie, J. Moore, V. Calvez, M. Desa, and C. Katlama. 1998. Intracellular phosphorylation of stavudine (d4T) and 3TC correlates with their antiviral activity in naïve and zidovudine (ZDV)-experienced HIV-uifected patients, abstr. 262, p. 146. In Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology and Human Health, Alexandria, Va.
19. Sommadossi, J. P., X. J. Zhou, J. Moore, D. V. Havlir, G. Friedland, C. Tierney, L. Smeaton, L. Fox, D. Richman, R. Pollard, and the NIAID ACTG 290 Investigators. 1998. Impairment of stavudine (d4T) phosphorylation in patients receiving a combination of zidovudine and d4T (ACTG 290), abstr. 3, p. 79. In Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology and Human Health, Alexandria, Va.
20. Tisdale, M., S. D. Kemp, N. R. Parry, and B. A. Larder. 1993. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl. Acad. Sci. USA 90:5653-5656.
21. Toraevik, Y., B. Jacobsson, S. Britton, and S. Eriksson. 1991. Intracellular metabolism of 3′-azidothymidine in isolated human peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 7:751-759.
22. Toyoshima, T., S. Kimura, S. Muramatsu, H. Takahagi, and K. Shimada. 1991. A sensitive nonisotopic method for the determination of intracellular azidothymidine 5′-mono-, 5′-di-, and 5′-triphosphate. Anal. Biochem. 196: 302-307.
23. Wang, L. H., J. Delehanty, M. R. Blum, L. Hulett, B., J. P. Sommadossi, and F. Rousseau. 1998. FTC (Emtricitabine): a potent and selective anti-HIV and anti-HBV agent demonstrating desirable pharmacokinetic characteristics, abstr. 415. In Program and abstracts of the 36th Annual Meeting of the Infectious Disease Society of America.
24. Wang, L. H., J. Delehanty, L. Hulett, B. McCreedy, J. P. Sommadossi, and F. Rousseau. 1998. High levels of intracellular FTC-triphosphate correlate with the potent antiviral activity of FTC in vivo, abstr. LB-2. In Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
25. Yarchoan, R., H. Mitsuya, R. V. Thomas, J. M. Pluda, N. R. Hartman, C. F. Perno, K. S. Marczyk, J. P. Allain, D. G. Johns, and S. Broder. 1989. In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science 245:412-415.
26. Zhu, Z., H. T. Ho, M. J. Hitchcock, and J. P. Sommadossi. 1990. Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) in human peripheral blood mononuclear cells. Biochem. Pharmacol. 39:R15-R19.